FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1830873 · Received September 8, 2010

Report

Report Number
2024168-2010-01871
Event Type
Injury
Date Received
September 8, 2010
Date of Event
August 15, 2010
Report Date
August 15, 2010
Manufacturer
ABBOTT VASCULAR CLONMEL
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DISSECTION IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MFR, DESIGN, OR LABELING. ALL STENT DELIVERY SYSTEMS ARE SUBJECTED TO A 100% VISUAL INSPECTION. IN ADDITION, A QUALITY CONTROL AUDIT INSPECTION IS USED TO VERIFY THE PRODUCT QUALITY.

Description of Event or Problem · 1

DEVICE ISSUE: NONE. ADVERSE EVENT: DISSECTION REQUIRING INTERVENTION. TIME OF ADVERSE EVENT: DURING THE PROCEDURE. IT WAS REPORTED THAT DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY THE PHYSICIAN WAS STENTING THE OSTIAL TO MID LEFT ANTERIOR DESCENDING ARTERY (LAD) WITH A 2.75 MM X 28 MM XIENCE V. THERE WAS A DISSECTION OF THE MID LAD AT THE DISTAL EDGE OF THE XIENCE V DURING IMPLANTATION. REPORTEDLY, THE LESION WAS CALCIFIED. THE PHYSICIAN USED ANOTHER 2.75 MM X 12 MM XIENCE V AT THE MID LAD TO TREAT THE DISTAL EDGE DISSECTION. NO PT EFFECTS WERE REPORTED. NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR CLONMEL NA 0012841

Patients

Seq Age Sex Outcome Treatment
1 55 YR Required Intervention WHISPER ES GUIDE WIRE| JL4 GUIDE CATHETER